Case ID: f-appx_499/html/0974-01.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

In re FENOFIBRATE PATENT LITIGATION. Lupin Atlantis Holdings S.A., Plaintiff-Appellant, v. Mylan Inc. and Mylan Pharmaceuticals Inc., Defendants-Appellees, and Ethypharm, S.A., Defendant.
    No. 2013-1141.
    United States Court of Appeals, Federal Circuit.
    Feb. 28, 2013.
    Robert F. Green, Leydig, Voit & Mayer, Ltd, of Chicago, IL, argued for plaintiff-appellant. With him on the brief were Christopher T. Griffith and Kate M. Les-ciotto; and Jamaica P. Szeliga, of Washington, DC. Of counsel was Jessica M. Tyrus.
    James H. Wallace, Jr., Wiley Rein LLP, of Washington, DC, argued for defendants-appellees. With him on the brief were Mark A. Pacella, Robert J. Scheffel, Claire J. Evans, Karin A. Hessler, and Adrienne G. Johnson.
    PROST, MOORE, and O’MALLEY, Circuit Judges.
   JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is

OrdeRed and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.